Guided Therapeutics (GTHP) Leases (2019 - 2025)
Guided Therapeutics recorded quarterly Leases of $686000.0 in Q4 2025, up 894.2% quarter-over-quarter from $69000.0 in Q3 2025, and up 386.52% year-over-year from $141000.0 in Q4 2024.
Guided Therapeutics' Leases history runs 7 years deep, the most recent figure standing at $686000.0 for Q4 2025.
- In Q4 2025, Leases rose 386.52% year-over-year to $686000.0; the TTM figure through Dec 2025 stood at $686000.0 (up 386.52% YoY), while the FY2025 annual figure was $686000.0, up 386.52% from the prior year.
- Leases came in at $686000.0 for Q4 2025 at Guided Therapeutics, up from $69000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $686000.0 in Q4 2025 to a low of $69000.0 in Q3 2025.
- A 5-year average of $279750.0 and a median of $275500.0 in 2023 frame the typical range for Leases.
- Across the five-year window, Leases surged 536.07% in 2021 and slumped 57.93% in 2025, its largest moves.
- Guided Therapeutics' Leases stood at $372000.0 in 2021, then declined by 18.55% to $303000.0 in 2022, then fell by 25.08% to $227000.0 in 2023, then plunged by 37.89% to $141000.0 in 2024, then soared by 386.52% to $686000.0 in 2025.
- According to Business Quant data, Leases over the past three periods registered $686000.0, $69000.0, and $94000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 547.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 99.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 73.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 396.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 155.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 686,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 686,000.00 |
| Sep 30, 2025 | 69,000.00 |
| Jun 30, 2025 | 94,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | 185,000.00 |
| Mar 31, 2024 | 207,000.00 |
| Dec 31, 2023 | 227,000.00 |
| Sep 30, 2023 | 247,000.00 |
| Jun 30, 2023 | 266,000.00 |
| Mar 31, 2023 | 285,000.00 |
| Dec 31, 2022 | 303,000.00 |
| Sep 30, 2022 | 321,000.00 |
| Jun 30, 2022 | 338,000.00 |
| Mar 31, 2022 | 355,000.00 |
| Dec 31, 2021 | 372,000.00 |
| Sep 30, 2021 | 388,000.00 |
| Jun 30, 2021 | 403,000.00 |
| Mar 31, 2021 | 426,000.00 |
| Dec 31, 2020 | 453,000.00 |
| Sep 30, 2020 | 61,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | 109,000.00 |
| Dec 31, 2019 | 132,000.00 |
| Sep 30, 2019 | 153,000.00 |
| Jun 30, 2019 | 175,000.00 |
| Mar 31, 2019 | 202,000.00 |